| [1] |
LIU Guiju, YUAN Wei, LYU Dinglin, HAN Qianqian, MEI Jiazhuan, ZHANG Haozhe.
Pristimerin sensitizes human esophageal squamous cell carcinoma cell strain ECA109/DDP to cisplatin
[J]. Basic & Clinical Medicine, 2026, 46(9): 1200-1206.
|
| [2] |
LIU Huoxi, HUANG Botian, ZHAO Yuntao, ZHANG Jiayang, WU Wenmei.
Overexpression of histone deacetylase 4 inhibits proliferation and invasion of colorectal cancer cells
[J]. Basic & Clinical Medicine, 2026, 46(8): 1051-1058.
|
| [3] |
FAN Wenyi, CHEN Yuwei, ZHENG Cuiting, LYU Jiarui, WANG Yanan.
Pifithrin-μ inhibits the proliferation of TSC2 mutant hepatocellular carcinoma cells
[J]. Basic & Clinical Medicine, 2026, 46(8): 1059-1067.
|
| [4] |
GUAN Xiaoxing.
Centrosomal protein 89 promotes the proliferation of neuroblastoma cell lines in vitro
[J]. Basic & Clinical Medicine, 2026, 46(6): 836-844.
|
| [5] |
LI Zhitao, BU Xuefeng, ZHANG Yongjun, MENG Nana, XIA Leizhou.
Farnesoid X receptor suppresses pancreatic cancer cell proliferation through negative regulation of matrix metalloproteinase 7
[J]. Basic & Clinical Medicine, 2026, 46(2): 250-255.
|
| [6] |
Zinati·NUERTAI, ROU Qian, ZHANG Meng, LIU Ying, CHENG Fang.
Spliceosome LSM4 inhibits the malignant progression of triple-negative breast cancer cell MDA-MB-231 through regulating DNA damage repair pathway
[J]. Basic & Clinical Medicine, 2026, 46(10): 1366-1374.
|
| [7] |
CHENG Zhijian, WANG Guoyu, HE Xijing, ZHAI Jingjing, WANG Tiaoning.
NG2 expression in primary culture of bone marrow derived-macrophages and its bioactivity
[J]. Basic & Clinical Medicine, 2026, 46(1): 1-4.
|
| [8] |
LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu.
Advances in the mechanism of action of the ring finger proteins family in breast cancer
[J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
|
| [9] |
WEI Xinwen, WEN Xiaojun, FAN Zhaoqiang, LAO Xifeng, ZHANG Luqing, ZHONG Ming.
CircAPLP2 inhibits proliferation, migration and invasion of human colorectal cancer cell lines through regulating miR-455-3p/STMN1 axis
[J]. Basic & Clinical Medicine, 2025, 45(9): 1208-1214.
|
| [10] |
AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR.
Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1
[J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
|
| [11] |
ZOU Qingbo, ZHANG Guochen, PAN Changjing.
Gypenoside inhibits the proliferation, migration and invasion of prostate cancer cell line PC-3
[J]. Basic & Clinical Medicine, 2025, 45(8): 1059-1065.
|
| [12] |
TIAN Ye, HE Quan, WANG Xiaojuan.
RPRD1B is highly expressed in human ovarian cancer cell lines and promotes tumor cell proliferation
[J]. Basic & Clinical Medicine, 2025, 45(8): 1066-1072.
|
| [13] |
JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua.
Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration
[J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
|
| [14] |
YIN Lijun, BO Yang, Anggelema, SONG Linlin.
LncRNA HIF1A-AS1 promotes the proliferation of gastric cancer cell lines through interfering with HIF1A
[J]. Basic & Clinical Medicine, 2025, 45(5): 627-636.
|
| [15] |
WANG Meng, SHEN Xuejing, LIU Jia, SHANG Lulu, ZHANG Mo.
Probe-based label-free SERS for identification of breast cancer-induced serum metabolic profiles in patients
[J]. Basic & Clinical Medicine, 2025, 45(5): 651-657.
|